QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
QQQ   431.52 (+0.11%)
AAPL   169.65 (-1.76%)
MSFT   415.99 (+0.57%)
META   500.34 (+0.02%)
GOOGL   154.77 (-0.06%)
AMZN   183.57 (-0.03%)
TSLA   155.97 (-3.41%)
NVDA   873.07 (+1.52%)
AMD   163.30 (+1.86%)
NIO   3.84 (-1.29%)
BABA   70.05 (-0.81%)
T   16.00 (-1.48%)
F   12.15 (-0.65%)
MU   121.17 (-0.16%)
GE   155.55 (+1.20%)
CGC   6.78 (-2.87%)
DIS   113.88 (+0.82%)
AMC   2.81 (+13.77%)
PFE   25.79 (-0.46%)
PYPL   63.73 (+0.35%)
XOM   118.36 (-1.10%)
OTCMKTS:AQSP

Acquired Sales (AQSP) Stock Price, News & Analysis

$1.71
0.00 (0.00%)
(As of 04/15/2024 ET)
Today's Range
$1.71
$1.71
50-Day Range
$1.60
$2.90
52-Week Range
$1.25
$11.00
Volume
N/A
Average Volume
2,325 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AQSP stock logo

About Acquired Sales Stock (OTCMKTS:AQSP)

LFTD Partners Inc. engages in manufacture, sale and distribution of cannabinoid-infused products. Its products includes beverages, shots, water, other liquids, water soluble nano drops or liquids, lotions, sprays, conditioners, creams, oils, pre-rolled hemp joints and hemp cigarettes, caviar cones, dabs, cartridges, gummies, saucy dmnds, CBG delta-8-THC flower, disposable delta-8-THC vapes, tinctures, powder, water packets, effervescent tablets, capsules, bath bombs, balms, body washes, gummies, food, chocolate, other edibles, and non-prescription cannabinoid formulations. The company was founded on January 2, 1986 and is headquartered in Jacksonville, FL.

AQSP Stock Price History

AQSP Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Apache acquiring Callon Petroleum
How Stock Options Are Taxed and Reported
Sales Representative Salary
S&P Global Is A Gem, But A Too Expensive One
See More Headlines
Receive AQSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acquired Sales and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Conglomerates
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:AQSP
CUSIP
00488M201
Fax
N/A
Employees
46
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Gerard M. Jacobs
    Chairman, Chief Executive Officer & Secretary
  • William C. Jacobs
    President, Chief Financial Officer & Treasurer
  • Nicholas S. Warrender
    Vice Chairman & Chief Operating Officer

AQSP Stock Analysis - Frequently Asked Questions

How have AQSP shares performed in 2024?

Acquired Sales' stock was trading at $2.14 at the beginning of 2024. Since then, AQSP stock has decreased by 20.2% and is now trading at $1.7075.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Acquired Sales own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acquired Sales investors own include Spero Therapeutics (SPRO), Cannabix Technologies (BLOZF), Bio-Rad Laboratories (BIO), BooksAMillion (BAMM), Avalara (AVLR), Athersys (ATHX), Arena Pharmaceuticals (ARNA), Aldeyra Therapeutics (ALDX) and Aerojet Rocketdyne (AJRD).

How do I buy shares of Acquired Sales?

Shares of AQSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AQSP) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners